Complete financial analysis of Ambu A/S (AMBFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ambu A/S, a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Aditya Consumer Marketing Limited (ACML.BO) Income Statement Analysis – Financial Results
- Greyson International, Inc. (GYSN) Income Statement Analysis – Financial Results
- Net Element, Inc. (NETE) Income Statement Analysis – Financial Results
- Universal Entertainment Corporation (6425.T) Income Statement Analysis – Financial Results
- Brookfield Infrastructure Finance ULC (BIPJ) Income Statement Analysis – Financial Results
Ambu A/S (AMBFF)
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.39B | 4.78B | 4.44B | 4.01B | 3.57B | 2.82B | 2.61B | 2.36B | 2.08B | 1.89B | 1.58B | 1.38B | 1.05B | 982.81M | 939.69M | 876.93M | 784.45M | 715.02M | 715.86M | 653.91M | 608.10M | 566.81M | 574.60M |
| Cost of Revenue | 2.19B | 2.06B | 1.89B | 1.51B | 1.36B | 1.18B | 1.06B | 1.02B | 960.00M | 973.00M | 786.00M | 704.00M | 469.75M | 436.84M | 429.20M | 416.34M | 365.01M | 340.91M | 348.51M | 312.97M | 302.88M | 285.63M | 303.00M |
| Gross Profit | 3.20B | 2.71B | 2.55B | 2.50B | 2.21B | 1.64B | 1.55B | 1.33B | 1.12B | 916.00M | 798.00M | 679.00M | 575.71M | 545.98M | 510.49M | 460.59M | 419.43M | 374.12M | 367.35M | 340.94M | 305.23M | 281.18M | 271.60M |
| Gross Profit Ratio | 59.38% | 56.82% | 57.47% | 62.37% | 62.01% | 58.05% | 59.36% | 56.52% | 53.93% | 48.49% | 50.38% | 49.10% | 55.07% | 55.55% | 54.33% | 52.52% | 53.47% | 52.32% | 51.32% | 52.14% | 50.19% | 49.61% | 47.27% |
| Research & Development | 325.00M | 295.00M | 281.00M | 225.00M | 157.00M | 103.00M | 111.00M | 76.00M | 66.00M | 54.00M | 44.00M | 33.00M | 22.89M | 26.27M | 0.00 | 0.00 | 27.34M | 26.86M | 27.17M | 0.00 | 17.35M | 17.94M | 14.43M |
| General & Administrative | 660.00M | 594.00M | 517.00M | 470.00M | 399.00M | 292.00M | 266.00M | 256.00M | 221.00M | 239.00M | 205.00M | 192.00M | 154.56M | 152.68M | 149.97M | 133.01M | 138.59M | -30.88M | -38.74M | 105.47M | 93.41M | 90.50M | 90.96M |
| Selling & Marketing | 1.57B | 1.52B | 1.63B | 1.47B | 1.23B | 762.00M | 607.00M | 539.00M | 481.00M | 382.00M | 347.00M | 292.00M | 238.01M | 216.18M | 204.82M | 184.32M | 165.28M | 151.98M | 147.39M | 143.94M | 133.30M | 123.24M | 123.13M |
| SG&A | 2.23B | 2.12B | 2.15B | 1.94B | 1.63B | 1.05B | 873.00M | 795.00M | 702.00M | 621.00M | 552.00M | 484.00M | 392.57M | 368.86M | 354.79M | 317.32M | 303.87M | 121.10M | 108.65M | 249.41M | 226.71M | 213.74M | 214.09M |
| Other Expenses | 0.00 | 0.00 | -49.00M | 0.00 | 0.00 | 0.00 | 0.00 | -10.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.56B | 2.41B | 2.43B | 2.16B | 1.78B | 1.16B | 984.00M | 871.00M | 768.00M | 675.00M | 600.00M | 521.00M | 418.95M | 401.66M | 392.15M | 384.24M | 678.18M | 304.87M | 284.69M | 280.34M | 241.90M | 228.88M | 236.06M |
| Cost & Expenses | 4.75B | 4.47B | 4.32B | 3.67B | 3.14B | 2.34B | 2.04B | 1.90B | 1.73B | 1.65B | 1.39B | 1.23B | 888.70M | 838.50M | 821.35M | 800.58M | 1.04B | 645.78M | 633.20M | 593.31M | 544.78M | 514.51M | 539.06M |
| Interest Income | 16.00M | 2.00M | 1.00M | 3.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.00M | 0.00 | 0.00 | 370.00K | 6.91M | 5.37M | 1.83M | 1.18M | 282.00K | 1.07M | 4.40M | 19.11M | 12.74M |
| Interest Expense | 27.00M | 86.00M | 32.00M | 26.00M | 28.00M | 20.00M | 31.00M | 33.00M | 30.00M | 29.00M | 38.00M | 20.00M | 5.00M | 13.64M | 6.67M | 8.04M | 19.87M | 11.06M | 9.21M | 8.70M | 10.97M | 19.11M | 0.00 |
| Depreciation & Amortization | 696.00M | 348.00M | 301.00M | 160.00M | 171.00M | 105.00M | 115.00M | 104.00M | 100.00M | 96.00M | 88.00M | 74.00M | 53.58M | 56.35M | 60.55M | 55.88M | -345.14M | 41.25M | 42.22M | 7.36M | 11.06M | 8.38M | 7.53M |
| EBITDA | 1.02B | 644.00M | 492.00M | 550.00M | 579.00M | 542.00M | 683.00M | 531.00M | 458.00M | 340.00M | 334.00M | 164.00M | 202.00M | 200.66M | 183.29M | 137.61M | 132.71M | 106.74M | 121.73M | 69.03M | 67.73M | 60.68M | 43.07M |
| EBITDA Ratio | 18.98% | 13.49% | 11.14% | 14.03% | 16.23% | 21.56% | 26.21% | 22.17% | 22.26% | 19.11% | 19.82% | 16.05% | 20.70% | 20.45% | 19.77% | 15.69% | -32.99% | 14.93% | 17.00% | 10.56% | 9.32% | 10.71% | 7.50% |
| Operating Income | 645.00M | 302.00M | -26.00M | 340.00M | 428.00M | 306.00M | 563.00M | 450.00M | 356.00M | 236.00M | 198.00M | 100.00M | 150.67M | 111.33M | 115.82M | 76.35M | 86.39M | 69.25M | 82.67M | 60.60M | 56.67M | 52.30M | 35.54M |
| Operating Income Ratio | 11.96% | 6.32% | -0.59% | 8.47% | 12.00% | 10.85% | 21.60% | 19.11% | 17.08% | 12.49% | 12.50% | 7.23% | 14.41% | 11.33% | 12.33% | 8.71% | 11.01% | 9.68% | 11.55% | 9.27% | 9.32% | 9.23% | 6.19% |
| Total Other Income/Expenses | -345.00M | -92.00M | -13.00M | -32.00M | -106.00M | 107.00M | -98.00M | -57.00M | -30.00M | -21.00M | 10.00M | -30.00M | -899.00K | -13.27M | 244.00K | -2.67M | -18.04M | -14.82M | -12.36M | -7.63M | -6.57M | -17.89M | -8.05M |
| Income Before Tax | 300.00M | 210.00M | 109.00M | 308.00M | 322.00M | 413.00M | 465.00M | 393.00M | 326.00M | 215.00M | 208.00M | 70.00M | 149.77M | 98.06M | 116.07M | 73.69M | 68.36M | 54.43M | 70.31M | 52.97M | 45.70M | 34.41M | 27.49M |
| Income Before Tax Ratio | 5.56% | 4.40% | 2.45% | 7.68% | 9.03% | 14.65% | 17.84% | 16.69% | 15.64% | 11.38% | 13.13% | 5.06% | 14.33% | 9.98% | 12.35% | 8.40% | 8.71% | 7.61% | 9.82% | 8.10% | 7.51% | 6.07% | 4.78% |
| Income Tax Expense | 65.00M | 42.00M | 16.00M | 61.00M | 81.00M | 96.00M | 128.00M | 92.00M | 76.00M | 63.00M | 57.00M | 22.00M | 35.05M | 28.85M | 32.01M | 17.92M | 18.35M | 11.65M | 21.89M | 15.28M | 12.41M | 8.41M | 12.50M |
| Net Income | 235.00M | 168.00M | 93.00M | 247.00M | 241.00M | 317.00M | 337.00M | 301.00M | 250.00M | 152.00M | 151.00M | 48.00M | 110.00M | 69.21M | 84.06M | 55.76M | 50.01M | 42.78M | 48.42M | 37.69M | 33.29M | 26.01M | 14.99M |
| Net Income Ratio | 4.36% | 3.52% | 2.09% | 6.15% | 6.76% | 11.24% | 12.93% | 12.78% | 12.00% | 8.05% | 9.53% | 3.47% | 10.52% | 7.04% | 8.94% | 6.36% | 6.38% | 5.98% | 6.76% | 5.76% | 5.47% | 4.59% | 2.61% |
| EPS | 0.88 | 0.64 | 0.37 | 0.98 | 0.98 | 1.30 | 1.39 | 1.27 | 1.05 | 0.63 | 0.64 | 0.20 | 0.47 | 0.30 | 0.36 | 0.24 | 0.21 | 0.18 | 0.21 | 0.16 | 0.14 | 0.11 | 0.00 |
| EPS Diluted | 0.88 | 0.64 | 0.37 | 0.98 | 0.97 | 1.28 | 1.36 | 1.24 | 1.03 | 0.61 | 0.62 | 0.20 | 0.46 | 0.29 | 0.35 | 0.24 | 0.21 | 0.18 | 0.21 | 0.16 | 0.14 | 0.11 | 0.00 |
| Weighted Avg Shares Out | 266.33M | 262.50M | 253.99M | 251.77M | 246.56M | 244.45M | 243.00M | 236.94M | 237.19M | 240.27M | 236.98M | 234.16M | 233.09M | 233.68M | 234.89M | 235.78M | 235.78M | 236.58M | 234.78M | 235.58M | 166.14M | 160.76M | 0.00 |
| Weighted Avg Shares Out (Dil) | 266.71M | 260.66M | 254.43M | 253.22M | 247.96M | 247.46M | 247.70M | 242.97M | 243.92M | 247.36M | 242.43M | 236.10M | 239.56M | 237.57M | 237.33M | 235.78M | 235.78M | 236.58M | 234.78M | 235.58M | 166.14M | 160.76M | 0.00 |
Ambu upgraded to Buy from Hold at Nordea
Nordea analyst Martin Brenoe upgraded Ambu to Buy from Hold with a DKK 160 price target.
Ambu A/S (AMBFF) Q4 2024 Earnings Call Transcript
Ambu A/S (OTCPK:AMBFF) Q4 2024 Earnings Conference Call November 5, 2024 4:00 AM ET Company Participants Britt Meelby Jensen - Chief Executive Officer Henrik Skak Bender - Chief Financial Officer Conference Call Participants Anchal Verma - JPMorgan Rickard Anderkrans -...
Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript
Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript
Ambu A/S (AMBFF) Q2 2023 Earnings Call Transcript
Ambu A/S (OTCPK:AMBFF) Q2 2023 Results Earnings Conference Call May 3, 2023 3:00 AM ET Company Participants Britt Meelby Jensen - Chief Executive Officer Thomas Frederik Schmidt - Executive Vice President and Chief Financial Officer Conference Call Participants Christian Sørup...
Ambu A/S (AMBFF) Q4 2022 Earnings Call Transcript
Ambu A/S (OTCPK:AMBFF) Q4 2022 Earnings Conference Call November 15, 2022 2:00 AM ET Company Participants Britt Meelby Jensen - Chief Executive Officer Thomas Schmidt - Executive Vice President & Chief Financial Officer Bassel Rifai - Chief Marketing Officer Conference...
Source: https://incomestatements.info
Category: Stock Reports